Rupture of the extracranial carotid arteries or their major branches is known as carotid blowout syndrome (CBS). CBS is a well-recognized complication of cancer of the head and neck and subsequent radiation therapy. A few treatment modalities are available, including open ligation and diff erent endovascular techniques, but questions regarding both the immediate and delayed complications of these procedures persist. In this case report, we describe the management of acute CBS in a 54-year-old man who had previously been treated for follicular thyroid carcinoma. Th e patient was hemorrhaging from a pseudoaneurysm of the left common carotid artery. A self-expanding polytetrafl uoroethylene (Tefl on) -covered stent was successfully deployed endovascularly, and this resulted in cessation of the bleeding and restoration of fl ow through the vessel. We examine the covered-stent approach to treating acute CBS, and we discuss other treatment approaches that have been described in the literature.
Introduction
Carotid blowout syndrome (CBS), or rupture of the extracranial carotid arteries or their major branches, is a feared complication of head and neck cancer that has been recognized in the literature for more than 3 decades. 1 Th e syndrome presents as three distinct clinical manifestations: acute CBS, impending CBS, and threatened CBS. 2 • Acute CBS describes an acute hemorrhage that cannot be stopped by packing or pressure.
• Impending CBS indicates a transcervical or transoral sentinel bleeding that can be stopped with packing or pressure.
• Th reatened CBS denotes an asymptomatic exposure of the carotid artery with radiologic fi ndings suggestive of a pseudoaneurysm or neoplastic invasion of the carotid system. Th e management of CBS remains a consistent source of controversy, especially in the emergency setting. We report a case of massive bleeding from a pseudoaneurysm of the common carotid artery that we treated with a selfexpanding polytetrafl uoroethylene (Tefl on) -covered stent in a patient with follicular thyroid carcinoma who had previously been treated with surgical excision and radiation therapy.
Case report
A 54-year-old man with a 4-month history of worsening dyspnea was brought to the emergency department in September 1999 with acute shortness of breath and hemoptysis of 3 days' duration. Computed tomography (CT) of the neck revealed the presence of a large thyroid mass that had invaded the trachea and extended below the clavicles. CT also detected a separate right parotid mass. Th e patient underwent a total thyroidectomy with neck dissection, resection of the anterior tracheal wall, a tracheostomy, and a right parotidectomy with facial nerve dissection. Pathologic evaluation revealed a poorly diff erentiated, metastatic follicular thyroid carcinoma (category T4N1, stage III) and a Warthin tumor of the parotid gland. Th e patient subsequently underwent treatment with fractionated external-beam radiation (50 Gy) and iodine-131 (100 mCi), and he initially appeared to be free of disease.
In December 2000, the patient returned with a recur-long 70% narrowing of the common carotid artery had been caused by tumor encasement. Exclusion of the pseudoaneurysm was performed with a 6 mm × 5-cm self-expanding Tefl on-covered stent (Viabahn; W.L. Gore & Associates; Flagstaff , Ariz.). Repeat DSA demonstrated a brisk fl ow of contrast through the covered stent (fi gure, B). Th ere was no residual pseudoaneurysm and no identifi able bleeding aft er removal of the packing. In view of the concern for massive bleeding, heparin was not used during the procedure, and the stent was deployed rapidly to avoid thrombus formation. Th e patient was discharged postoperatively with arrangements made for outpatient hospice out of state. As a consequence, he was lost to follow-up 4 months aft er discharge.
Discussion
Th e incidence of CBS following major head and neck cancer resections has been consistently reported as 3 to 5%. 1 In patients with head and neck cancer, irradiation is associated with a 7.6-fold increase in the risk of CBS because of obliteration of the vasa vasorum, premature atherosclerosis, and adventitial fi brosis. 3 CBS has been associated with a 60% neurologic morbidity rate and a 40% mortality rate, although more recent data suggest that these rates may actually be lower. 4 Th e management of acute CBS has been a source of rence that had invaded the laryngotracheal complex. An elective total laryngectomy was performed, and an additional course of 131 I treatment (150 mCi) was administered. Th e patient returned in February 2002 with a recurrence in the area surrounding his tracheostome. Even aft er further external-beam radiotherapy (40 Gy), he continued to experience hemoptysis and local bleeding. Arteriography with selective embolization of bilateral external carotid arteries and several feeder branches was performed, and the bleeding ceased. Additionally, another round of external-beam radiotherapy was administered for palliation. Th e patient did not begin to experience any further acute diffi culties until April 2005, when disease involving the tracheostome again recurred, causing airway obstruction. Th is was addressed by intermittently debulking the tumor for palliation.
In September 2005, aft er a debulking procedure, the patient experienced massive bleeding from the left aspect of the tracheostome. Th e hemorrhage was initially controlled with packing and pressure. Th e patient was subsequently transferred to the interventional radiology suite, where he underwent arteriography. Selective digital subtraction arteriography (DSA) detected a 3-mm pseudoaneurysm arising from the mid-left common carotid artery; the site of the pseudoaneurysm corresponded to the site of the bleeding (fi gure, A). A 1.5-cm signifi cant controversy in the literature. Further compounding the issue is the fact that most studies on the subject are case reports or retrospective reviews. Th e techniques that have been proposed by various authors have not been shown to be applicable in all situations, and each technique has the potential for adverse complications that must be considered carefully. 1, 5 Th e management strategy outlined in the earliest reports of this syndrome favored ligation of the artery proximal and distal to the defect. While this is technically diffi cult because of the hemodynamic instability of the patient and the status of the oft en necrotic, infected, and tumor-invaded operative fi eld, ligation was considered to be an eff ective means of achieving hemostasis. 6, 7 However, the complication rate remained unacceptably high. Th e major cause of mortality and morbidity was cerebral ischemia secondary to a lack of collateral fl ow, to thromboembolism from the acutely occluded artery, or to a delayed failure of collateral arteries. 1 Newer approaches to treating CBS have involved endovascular techniques such as permanent balloon occlusion (PBO) and selective coil embolization. Endovascular techniques have an advantage in that they can be performed together with angiography, which has become the gold standard for the evaluation of both the bleeding site and the patency of cerebral circulation. 1, 5 Proponents of PBO suggest that angiography coupled with measurement of arterial back pressure (stump pressure) in the occluded vessel reliably predicts patent cerebral circulation and therefore decreases the risk of adverse neurologic outcomes.
Citardi et al reported no serious neurologic complications in a series of 12 patients treated with PBO. 2 Selective coil embolization might yield an even lower complication rate because it leaves the main carotid trunks intact. Morrissey et al reported 13 cases in which hemostasis was achieved with embolization, with 1 case of permanent hemiparesis and 2 cases of temporary hemiplegia. 4 However, other authors have suggested that PBO may be associated with as much as a 15 to 20% incidence of immediate or delayed cerebral ischemia, especially in patients who are at high risk for carotid occlusion. 8 Even when balloon occlusion testing prior to PBO is clinically feasible, one is still unable to reliably predict which patients will develop delayed ischemia. 2 More recently, investigation has focused on the use of stents to manage CBS. As with other endovascular techniques, stents facilitate hemostasis without the potential for cranial nerve injury in tumor-involved operative fi elds. Additionally, the use of stents potentially avoids the adverse outcomes associated with ligation and PBO because stents maintain the patency of the vessel. Stents can be rapidly deployed in emergency situations in which rapid hemostasis is required. 1, 5 Treatment of CBS with various types of stents (e.g., covered, uncovered, balloon-expanding, and selfexpanding) has been previously described. Lesley et al reported their retrospective review of 16 CBS events in 12 patients who had undergone endovascular reconstruction of the carotid artery with a covered stent. 8 Th ese were single-wire woven stents with proximal and distal bare segments and a covered segment in the middle. Hemostasis was achieved, although 4 of these patients required retreatment, thus demonstrating a recurrence rate similar to that associated with PBO. No treatmentrelated strokes or deaths occurred, which led the authors to the conclusion that the use of a stent is as effi cacious as PBO and may be safer in those patients who would be at high risk for stroke following PBO.
More recently, Kim et al reported a series of 4 cases of carotid blowout in which a self-expanding Tefl oncovered nitinol (nickel-titanium) stent was used. 9 Hemostasis was achieved in each case, and recurrent bleeding was noted only in the 2 patients in whom the newly designed stent had not been used initially. Hemostasis was eventually achieved in these 2 patients when the new stent was placed. Th ese stents provide durability, and unlike other covered stents, they may be used when there is a large mismatch between the caliber of the common carotid artery and that of the internal or external carotid arteries.
Despite reports of the immediate success of stents in treating carotid artery blowout, the current literature contains no follow-up data on patients treated with this technique beyond 3 years, and therefore some authors suggest that stents may not be a viable long-term option. 10, 11 Because stents are foreign bodies that are oft en placed in vessels compromised by infection, malignancy, and radiation necrosis, there are risks of stent infection with occlusion, stent failure with rehemorrhage, and stent extrusion through the vessel. 10, 11 Simental et al reported delayed complications in 2 cases of stent use for the control of carotid artery rupture in patients with cervical malignancy complicated by infection and radiation necrosis. 11 In both cases, the stent was extruded, which led to thrombosis and cerebrovascular accident between 1 and 2 months following placement.
More recently, Pyun et al reported recurrent hemorrhage in 6 of 7 patients who were initially treated for CBS with a covered stent. 12 While 4 of the 6 hemorrhages recurred at the site of the stent insertion, the other 2 re-bled at a diff erent site. Th e group of 4 patients with same-site recurrence diff ered from the group of 2 in that all 4 patients had an infected fi stula that required fl ap surgery or incisional drainage; this illustrated the function of uncontrolled contamination as an important predictor of poststent rebleeding.
In a similar study, Chang et al described a series of 8 patients who were treated for CBS with endovascular reconstruction. 13 Th ere were 3 immediate complications (stroke in 1 patient and asymptomatic thrombosis of the carotid in 2 others) and 8 delayed complications in 7 patients (rebleeding in 4 patients, carotid thrombosis in 3 patients, and brain abscess formation in 1 of the 2 patients with carotid thrombosis). With respect to technical outcome, none of the 3 patients who were followed for longer than 3 months maintained patency in the stented carotid. Recognizing the role of ongoing infection in cases of recurrent hemorrhage and thrombotic occlusion, these authors recommended the use of prophylactic antibiotic treatment when stenting patients with CBS.
Based on the poor hemostatic and technical outcomes seen in the aforementioned study, Chang et al examined their stenting technique and found that distal marginal stenosis was commonly the cause of occlusion and that inadequate coverage of the ongoing pathologic lesion was likely contributing to the rebleeding. Th us, they suggested that CTs be reviewed for signs of dynamic pathology (i.e., tumor recurrence, wound infection, or radiation necrosis) and that the fi eld of any previous irradiation be assessed prior to choosing a stent length and planning placement. Aft er modifying their technique thus, Chang et al followed up with a retrospective study to compare the outcomes of 11 patients who had undergone endovascular reconstruction with a selfexpanding stent graft , with the outcomes of 13 patients who had undergone endovascular deconstruction with balloons, coils, or acrylic adhesive in the management of CBS. 14 Th ere were no signifi cant diff erences between the 2 treatment groups in the duration of hemostasis, initial and delayed complications (including rebleeding), and survival time. Th e rate of recurrence did, however, correlate with the clinical and angiographic severity of CBS. Across both groups, patients with acute CBS had a signifi cantly higher bleeding rate than did those with impending or threatened CBS.
In light of the fi ndings in the present case and in others like it that have been reported in the literature, we believe that the use of stents appears to be a safe and effi cacious emergency treatment option for CBS in patients who are either at signifi cant risk for neurologic morbidity (i.e., those with an incomplete circle of Willis on angiography) or too unstable to undergo occlusion testing. Clearly, there is a need for more extensive investigation into the long-term eff ectiveness of this treatment modality. However, whether stenting represents a temporary or long-term treatment option for CBS secondary to head and neck malignancy and radiation therapy may ultimately be irrelevant. Oft en, these patients have terminal prognoses and may not be candidates for more defi nitive treatment (i.e., ligation and bypass) because of the increased risks of general anesthesia and major surgery, as well as the technical limitations inherent in performing these procedures in this patient population.
